Literature DB >> 19346366

Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo.

Adam MacNeil1, Mary G Reynolds, Darin S Carroll, Kevin Karem, Zach Braden, Ryan Lash, Amba Moundeli, Jean-Vivien Mombouli, Aisha O Jumaan, D Scott Schmid, Inger K Damon.   

Abstract

Monkeypox virus and varicellazoster virus (VZV) cause visually similar rash illnesses. Monkeypox is more virulent, with fatality rates up to 10%. In June 2007, reports were received of a rash illness outbreak in isolated villages in Likouala district, Republic of the Congo. Blood specimens were obtained from 142 individuals reporting rash illness between January and September 2007 from four villages in Likouala. Thirty-seven cases of probable VZV were identified based on low VZV IgG avidity; cases occurred in all four villages. No probable monkeypox cases with orthopoxvirus-positive IgM responses were observed; however, three possible monkeypox cases, in individuals < 26 years of age, with rash illness occurring > 56 days before sampling and positive orthopoxvirus-specific IgG responses, were identified. Remoteness and delays in reporting limited collection of acute diagnostic specimens. Improvements in rash illness surveillance and infection control, through training of health workers and timely acquisition of diagnostic specimens, are being undertaken.

Entities:  

Mesh:

Year:  2009        PMID: 19346366

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.

Authors:  Reena H Doshi; Vivian H Alfonso; Patrick Mukadi; Nicole A Hoff; Sue Gerber; Ado Bwaka; Stephen G Higgins; Cyrus Sinai; Brian Cowell; Guillaume Ngoie Mwamba; Emile Okitolonda; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  Pediatr Infect Dis J       Date:  2018-02       Impact factor: 2.129

2.  New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization.

Authors:  Yana Khlusevich; Andrey Matveev; Lyudmila Emelyanova; Elena Goncharova; Natalia Golosova; Ivan Pereverzev; Nina Tikunova
Journal:  Viruses       Date:  2022-06-05       Impact factor: 5.818

3.  Varicella in Tshuapa Province, Democratic Republic of Congo, 2009-2014.

Authors:  Jessica Leung; Andrea M McCollum; Kay Radford; Christine Hughes; Adriana S Lopez; Sarah Anne J Guagliardo; Beatrice Nguete; Toutou Likafi; Joelle Kabamba; Jean Malekani; Robert Shongo Lushima; Elisabeth Pukuta; Stomy Karhemere; Jean Jacques Muyembe Tamfum; Mary G Reynolds; Emile Wemakoy Okitolonda; D Scott Schmid; Mona Marin
Journal:  Trop Med Int Health       Date:  2019-05-22       Impact factor: 2.622

4.  Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox.

Authors:  Scott Parker; Nanhai G Chen; Scott Foster; Hollyce Hartzler; Ed Hembrador; Dennis Hruby; Robert Jordan; Randall Lanier; George Painter; Wesley Painter; John E Sagartz; Jill Schriewer; R Mark Buller
Journal:  Antiviral Res       Date:  2012-02-18       Impact factor: 10.103

5.  Serologic evidence of human orthopoxvirus infections in Sierra Leone.

Authors:  Adam Macneil; Jason Abel; Mary G Reynolds; Rr Lash; Richard Fonnie; Lansana D Kanneh; Willie Robert; Victor K Lungay; Augustine Goba; Lina M Moses; Inger K Damon; Kevin Karem; Daniel G Bausch
Journal:  BMC Res Notes       Date:  2011-10-28

6.  Simple technique for in field samples collection in the cases of skin rash illness and subsequent PCR detection of orthopoxviruses and varicella zoster virus.

Authors:  Catherine Dumont; Leonid M Irenge; Edmond K Magazani; Daniel Garin; Jean-Jacques T Muyembe; Mostafa Bentahir; Jean-Luc Gala
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

7.  Rapid and sensitive point-of-care detection of Orthopoxviruses by ABICAP immunofiltration.

Authors:  Daniel Stern; Victoria A Olson; Scott K Smith; Marko Pietraszczyk; Lilija Miller; Peter Miethe; Brigitte G Dorner; Andreas Nitsche
Journal:  Virol J       Date:  2016-12-09       Impact factor: 4.099

8.  Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo.

Authors:  Nicole A Hoff; Douglas S Morier; Neville K Kisalu; Sara C Johnston; Reena H Doshi; Lisa E Hensley; Emile Okitolonda-Wemakoy; Jean Jacques Muyembe-Tamfum; James O Lloyd-Smith; Anne W Rimoin
Journal:  Ecohealth       Date:  2017-09-11       Impact factor: 4.464

9.  A phylogeographic investigation of African monkeypox.

Authors:  Yoshinori Nakazawa; Matthew R Mauldin; Ginny L Emerson; Mary G Reynolds; R Ryan Lash; Jinxin Gao; Hui Zhao; Yu Li; Jean-Jacques Muyembe; Placide Mbala Kingebeni; Okito Wemakoy; Jean Malekani; Kevin L Karem; Inger K Damon; Darin S Carroll
Journal:  Viruses       Date:  2015-04-22       Impact factor: 5.048

10.  Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo.

Authors:  Lynda Osadebe; Christine M Hughes; Robert Shongo Lushima; Joelle Kabamba; Beatrice Nguete; Jean Malekani; Elisabeth Pukuta; Stomy Karhemere; Jean-Jacques Muyembe Tamfum; Emile Wemakoy Okitolonda; Mary G Reynolds; Andrea M McCollum
Journal:  PLoS Negl Trop Dis       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.